Sens. Cramer, Durbin, Smith Applaud Inclusion of Their Bill to Lower Insulin Costs in Today's Appropriations Package

***Click here for audio.***

WASHINGTON – U.S. Senators Kevin Cramer (R-ND), Dick Durbin (D-IL), and Tina Smith (D-MN) today applauded the inclusion in the Fiscal Year (FY) 2020 appropriations bill of their Affordable Insulin Approvals Now Act, a bipartisan bill to speed up approvals of lower-cost, generic insulin products in order to help reduce prices of this life-saving medication for patients.  Approximately 7.5 million Americans with diabetes rely on insulin every day to survive, yet the drug has experienced a price increase of more than 600 percent over the past two decades in the United States. 

“Increasing the amount of generic and low-cost insulin in the market will decrease the burden placed on patients who rely on these drugs,” said Senator Cramer. “I am pleased to see our bipartisan bill included in this package, and I plan to keep working to find more ways to encourage competition and free market solutions to the rising cost of health care."